Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
Zentalis Pharmaceuticals (ZNTL) Ownership Overview
29.49% Insiders
5.81% Mutual Funds
18.34% Other Institutional Investors
4.35% ETFs
42.00% Public Companies and
Individual Investors
The ownership structure of Zentalis Pharmaceuticals (ZNTL) stock is a mix of institutional, retail, and individual investors. Approximately 28.51% of the company’s stock is owned by Institutional Investors, 29.49% is owned by Insiders, and 42.00% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 10, 2026 | xxxxxxxxxxxxx | $7969 | |
Feb 10, 2026 | xxxxxxxxxxxxx | $21160 | |
Feb 10, 2026 | xxxxxxxxxxxxx | $80557 | |
Feb 04, 2026 | xxxxxxxxxxxxx | $6477 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $122728 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $1292517 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,959,973 | Institution | 19.32% | 36,575,129 | |
| 13,509,973 | Insider | 18.70% | 35,396,129 | |
| 6,459,973 | Insider | 8.94% | 16,925,129 | |
| 2,390,068 | Institution | 3.31% | 6,261,978 | |
| 2,131,700 | Institution | 2.95% | 5,585,054 | |
| 957,420 | Institution | 1.33% | 2,508,440 | |
| 676,400 | Institution | 0.94% | 1,772,168 | |
| 530,582 | Institution | 0.73% | 1,390,125 | |
| 476,289 | Institution | 0.66% | 1,247,877 | |
| 338,795 | Insider | 0.47% | 887,643 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,131,700 | Institution | 2.95% | 5,585,054 | |
| 676,400 | Institution | 0.94% | 1,772,168 | |
| 476,289 | Institution | 0.66% | 1,247,877 | |
| 209,330 | Institution | 0.29% | 548,445 | |
| 159,467 | Institution | 0.22% | 417,804 | |
| 137,162 | Institution | 0.19% | 359,364 | |
| 108,264 | Institution | 0.15% | 283,652 | |
| 77,300 | Institution | 0.11% | 202,526 | |
| 52,572 | Institution | 0.07% | 137,739 | |
| 41,861 | Institution | 0.06% | 109,676 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,694,426 | Institution | 2.35% | 4,049,678 | |
| 543,757 | Institution | 0.75% | 1,299,579 | |
| 236,122 | Institution | 0.33% | 604,472 | |
| 190,418 | Institution | 0.26% | 487,470 | |
| 154,108 | Institution | 0.21% | 403,763 | |
| 151,885 | Institution | 0.21% | 363,005 | |
| 81,063 | Institution | 0.11% | 207,521 | |
| 49,267 | Institution | 0.07% | 129,080 | |
| 43,767 | Institution | 0.06% | 112,044 | |
| 2,171 | Institution | <0.01% | 38,969 |
FAQ
Who Owns Zentalis Pharmaceuticals (ZNTL)?
According to the latest TipRanks data, approximately 18.34% of the company's stock is held by institutional investors, 29.49% is held by insiders, and 42.00% is held by retail investors.
What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.34% of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors.
What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors?
According to the latest TipRanks data, approximately 42.00% of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors.
Who owns the most shares of Zentalis Pharmaceuticals (ZNTL)?
Christopher J. Burke owns the most shares of Zentalis Pharmaceuticals (ZNTL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.